Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoChange DetectedNew help/navigation sections have been added: How to Read a Study Record, Common Questions, and How to Join a Study, and the Intervention/Treatment label has been reformatted. The page now shows Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.5%

- Check10 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This appears to be a small maintenance update to the page's documentation rather than a substantive content change.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows revision v3.5.4, indicating a maintenance/update to the page. There are no changes to the trial details or content evident in this revision.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, reflecting a site/software release rather than a change to the underlying clinical trial information.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.5.0 is now active, replacing v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.